Table of Contents Author Guidelines Submit a Manuscript
Parkinson’s Disease
Volume 2010, Article ID 427810, 10 pages
http://dx.doi.org/10.4061/2010/427810
Research Article

Subtle Cardiovascular Dysfunction in the Unilateral 6-Hydroxydopamine-Lesioned Rat

Department of Pharmacology, Bosch Institute and School of Medical Sciences, University of Sydney, NSW 2006, Australia

Received 26 August 2009; Revised 17 November 2009; Accepted 30 December 2009

Academic Editor: Mark Robert Cookson

Copyright © 2010 K. Slack et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. S. Forno, “Neuropathology of Parkinson's disease,” Journal of Neuropathology and Experimental Neurology, vol. 55, no. 3, pp. 259–272, 1996. View at Google Scholar · View at Scopus
  2. J. Parkinson, “An essay on the shaking palsy. 1817,” The Journal of Neuropsychiatry and Clinical Neurosciences, vol. 14, no. 2, pp. 223–236, 2002. View at Google Scholar · View at Scopus
  3. J. M. Fearnley and A. J. Lees, “Ageing and Parkinson's disease: substantia nigra regional selectivity,” Brain, vol. 114, no. 5, pp. 2283–2301, 1991. View at Google Scholar · View at Scopus
  4. O. Hornykiewicz, “Chemical neuroanatomy of the basal ganglia—normal and in Parkinson's disease,” Journal of Chemical Neuroanatomy, vol. 22, no. 1-2, pp. 3–12, 2001. View at Publisher · View at Google Scholar · View at Scopus
  5. E. R. Barbosa, J. C. P. Limongi, and J. L. Cummings, “Parkinson's disease,” Psychiatric Clinics of North America, vol. 20, no. 4, pp. 769–790, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Korchounov, K. R. Kessler, and H. I. Schipper, “Differential effects of various treatment combinations on cardiovascular dysfunction in patients with Parkinson's disease,” Acta Neurologica Scandinavica, vol. 109, no. 1, pp. 45–51, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. W. H. Jost, “Autonomic dysfunctions in idiopathic Parkinson's disease,” Journal of Neurology, vol. 250, supplement 1, pp. I28–I30, 2003. View at Google Scholar · View at Scopus
  8. G. Micieli, P. Tosi, S. Marcheselli, and A. Cavallini, “Autonomic dysfunction in Parkinson's disease,” Neurological Sciences, vol. 24, supplement 1, pp. S32–S34, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. J. H. Pazo and J. E. Belforte, “Basal ganglia and functions of the autonomic nervous system,” Cellular and Molecular Neurobiology, vol. 22, no. 5-6, pp. 645–654, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Bruguerolle and N. Simon, “Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function,” Clinical Neuropharmacology, vol. 25, no. 4, pp. 194–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. R. K. W. Schwarting and J. P. Huston, “The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments,” Progress in Neurobiology, vol. 50, no. 2-3, pp. 275–331, 1996. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Wichmann and M. R. Delong, “Functional and pathophysiological models of the basal ganglia,” Current Opinion in Neurobiology, vol. 6, no. 6, pp. 751–758, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. J. M. Henderson, S. Watson, G. M. Halliday, T. Heinemann, and M. Gerlach, “Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat,” Behavioural Brain Research, vol. 139, no. 1-2, pp. 105–113, 2003. View at Publisher · View at Google Scholar · View at Scopus
  14. V. Ben and B. Bruguerolle, “Effects of bilateral striatal 6-OHDA lesions on circadian rhythms in the rat: a radiotelemetric study,” Life Sciences, vol. 67, no. 13, pp. 1549–1558, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Sakata, H. Sei, K. Toida, H. Fujihara, R. Urushihara, and Y. Morita, “Mesolimbic dopaminergic system is involved in diurnal blood pressure regulation,” Brain Research, vol. 928, no. 1-2, pp. 194–201, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Leng, A. Mura, B. Hengerer, J. Feldon, and B. Ferger, “Effects of blocking the dopamine biosynthesis and of neurotoxic dopamine depletion with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on voluntary wheel running in mice,” Behavioural Brain Research, vol. 154, no. 2, pp. 375–383, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. R. K. W. Schwarting, A. E. Bonatz, R. J. Carey, and J. P. Huston, “Relationships between indices of behavioral asymmetries and neurochemical changes following mesencephalic 6-hydroxydopamine injections,” Brain Research, vol. 554, no. 1-2, pp. 46–55, 1991. View at Google Scholar · View at Scopus
  18. V. Ben, O. Blin, and B. Bruguerolle, “Time-dependent striatal dopamine depletion after injection of 6-hydroxydopamine in the rat. Comparison of single bilateral and double bilateral lesions,” Journal of Pharmacy and Pharmacology, vol. 51, no. 12, pp. 1405–1408, 1999. View at Google Scholar · View at Scopus
  19. M. Turgut, “Asymmetry of sympathetic activity in a rat model of Parkinson's disease induced by 6-hydroxydopamine: haemodynamic, electrocardiographic and biochemical changes,” Research in Experimental Medicine, vol. 197, no. 5, pp. 281–292, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Hashimoto, M. Kuwahara, H. Tsubone, and S. Sugano, “Diurnal variation of autonomic nervous activity in the rat. Investigation by power spectral analysis of heart rate variability,” Journal of Electrocardiology, vol. 32, no. 2, pp. 167–171, 1999. View at Publisher · View at Google Scholar · View at Scopus
  21. J. M. Henderson, L. E. Annett, L. J. Ryan et al., “Subthalamic nucleus lesions induce deficits as well as benefits in the hemiparkinsonian rat,” European Journal of Neuroscience, vol. 11, no. 8, pp. 2749–2757, 1999. View at Publisher · View at Google Scholar · View at Scopus
  22. C. V. Borlongan and P. R. Sanberg, “Elevated body swing test: a new behavioral parameter for rats with 6-hydroxydopamine-induced hemiparkinsonism,” Journal of Neuroscience, vol. 15, no. 7, part 2, pp. 5372–5378, 1995. View at Google Scholar · View at Scopus
  23. K. Kramer, S. A. van Acker, H.-P. Voss, J. A. Grimbergen, W. J. F. van der Vijgh, and A. Bast, “Use of telemetry to record electrocardiogram and heart rate in freely moving mice,” Journal of Pharmacological and Toxicological Methods, vol. 30, no. 4, pp. 209–215, 1993. View at Google Scholar · View at Scopus
  24. G. Paxinos and C. Watson, The Rat Brain in Stereotactic Coordinates, Academic Press, San Diego, Calif, USA, 1998.
  25. M. Kamath and E. Fallen, Correction of the Heart Rate Variability Signal for Ectopic and Missing Beats, Futura, Mount Kisko, NY, USA, 1995.
  26. J. P. Saul, P. Albrecht, R. D. Berger, and R. J. Cohen, “Analysis of long term heart rate variability: methods, 1/f scaling and implications,” Computers in Cardiology, vol. 14, pp. 419–422, 1988. View at Google Scholar · View at Scopus
  27. M. Malik, J. T. Bigger Jr., A. J. Camm et al., “Heart rate variability. Standards of measurement, physiological interpretation, and clinical use,” European Heart Journal, vol. 17, no. 3, pp. 354–381, 1996. View at Google Scholar
  28. M. Kuwahara, K. Yayou, K. Ishii, S. Hashimoto, H. Tsubone, and S. Sugano, “Power spectral analysis of heart rate variability as a new method for assessing autonomic activity in the rat,” Journal of Electrocardiology, vol. 27, no. 4, pp. 333–337, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. U. Ungerstedt, “6-hydroxy-dopamine induced degeneration of central monoamine neurons,” European Journal of Pharmacology, vol. 5, no. 1, pp. 107–110, 1968. View at Google Scholar · View at Scopus
  30. U. Ungerstedt and G. W. Arbuthnott, “Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system,” Brain Research, vol. 24, no. 3, pp. 485–493, 1970. View at Google Scholar · View at Scopus
  31. T. Schallert and S. Hall, “‘Disengage’ sensorimotor deficit following apparent recovery from unilateral dopamine depletion,” Behavioural Brain Research, vol. 30, no. 1, pp. 15–24, 1988. View at Google Scholar · View at Scopus
  32. J. L. Hudson, C.-S. Fong, S. J. Boyson, and B. J. Hoffer, “Conditioned apomorphine-induced turning in 6-OHDA-lesioned rats,” Pharmacology Biochemistry and Behavior, vol. 49, no. 1, pp. 147–154, 1994. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Hirsch, A. M. Graybiel, and Y. A. Agid, “Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease,” Nature, vol. 334, no. 6180, pp. 345–348, 1988. View at Google Scholar · View at Scopus
  34. J. Sian, M. Gerlach, M. B. H. Youdim, and P. Riederer, “Parkinson's disease: a major hypokinetic basal ganglia disorder,” Journal of Neural Transmission, vol. 106, no. 5-6, pp. 443–476, 1999. View at Publisher · View at Google Scholar · View at Scopus
  35. M. Gerlach and P. Riederer, “Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man,” Journal of Neural Transmission, vol. 103, no. 8-9, pp. 987–1041, 1996. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Salin, M. D. Hajji, and L. Kerkerian-le Goff, “Bilateral 6-hydroxydopamine-induced lesion of the nigrostriatal dopamine pathway reproduces the effects of unilateral lesion on substance P but not on enkephalin expression in rat basal ganglia,” European Journal of Neuroscience, vol. 8, no. 8, pp. 1746–1757, 1996. View at Google Scholar · View at Scopus
  37. M. T. Lin, B. L. Tsay, and F. F. Chen, “Activation of dopaminergic receptors within the caudate-putamen complex facilitates reflex bradycardia in the rat,” Japanese Journal of Physiology, vol. 32, no. 3, pp. 431–442, 1982. View at Google Scholar · View at Scopus
  38. J. H. Pazo and J. H. Medina, “Cholinergic mechanisms within the caudate nucleus mediate changes in blood pressure,” Neuropharmacology, vol. 22, no. 6, pp. 717–720, 1983. View at Publisher · View at Google Scholar · View at Scopus
  39. J. J. Wu, C. J. Shih, and M. T. Lin, “Tachycardia, hypertension and decreased reflex bradycardia produced by striatal lesions induced by kainic acid,” Neuropharmacology, vol. 23, no. 11, pp. 1231–1235, 1984. View at Publisher · View at Google Scholar · View at Scopus
  40. A. C. E. Linthorst, M. Van den Buuse, W. De Jong, and D. H. G. Versteeg, “Electrically stimulated [3H]dopamine and [14C]acetylcholine release from nucleus caudatus slices: differences between spontaneously hypertensive rats and Wistar-Kyoto rats,” Brain Research, vol. 509, no. 2, pp. 266–272, 1990. View at Publisher · View at Google Scholar · View at Scopus
  41. M.-T. Lin and J.-J. Yang, “Stimulation of the nigrostriatal dopamine system produces hypertension and tachycardia in rats,” American Journal of Physiology, vol. 266, no. 6, part 2, pp. H2489–H2496, 1994. View at Google Scholar
  42. A. Lessard and R. Couture, “Modulation of cardiac activity by tachykinins in the rat substantia nigra,” British Journal of Pharmacology, vol. 134, no. 8, pp. 1749–1759, 2001. View at Google Scholar · View at Scopus
  43. A. Lessard, M. M. Campos, W. Neugebauer, and R. Couture, “Implication of nigral tachykinin NK3 receptors in the maintenance of hypertension in spontaneously hypertensive rats: a pharmacologic and autoradiographic study,” British Journal of Pharmacology, vol. 138, no. 4, pp. 554–563, 2003. View at Publisher · View at Google Scholar · View at Scopus
  44. J. M. Thornton, T. Aziz, D. Schlugman, and D. J. Paterson, “Electrical stimulation of the midbrain increases heart rate and arterial blood pressure in awake humans,” Journal of Physiology, vol. 539, no. 2, pp. 615–621, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. D. S. Goldstein, “Dysautonomia in Parkinson's disease: neurocardiological abnormalities,” Lancet Neurology, vol. 2, no. 11, pp. 669–676, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. M. S. Kafka, A. Wirz-Justice, D. Naber, R. Y. Moore, and M. A. Benedito, “Circadian rhythms in rat brain neurotransmitter receptors,” Federation Proceedings, vol. 42, no. 11, pp. 2796–2801, 1983. View at Google Scholar · View at Scopus
  47. D. G. Harper, W. Tornatzky, and K. A. Miczek, “Stress induced disorganization of circadian and ultradian rhythms: comparisons of effects of surgery and social stress,” Physiology and Behavior, vol. 59, no. 3, pp. 409–419, 1996. View at Publisher · View at Google Scholar · View at Scopus
  48. F. Prudian, M. Gantenbein, A. L. Pelissier, L. Attolini, and B. Bruguerolle, “Daily rhythms of heart rate, temperature and locomotor activity are modified by anaesthetics in rats: a telemetric study,” Naunyn-Schmiedeberg's Archives of Pharmacology, vol. 355, no. 6, pp. 774–778, 1997. View at Publisher · View at Google Scholar · View at Scopus
  49. G. Pierangeli, F. Provini, P. Maltoni et al., “Nocturnal body core temperature falls in Parkinson's disease but not in multiple-system atrophy,” Movement Disorders, vol. 16, no. 2, pp. 226–232, 2001. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Bootsma, C. A. Swenne, H. H. Van Bolhuis, P. C. Chang, V. M. Cats, and A. V. G. Bruschke, “Heart rate and heart rate variability as indexes of sympathovagal balance,” American Journal of Physiology, vol. 266, no. 4, part 2, pp. H1565–H1571, 1994. View at Google Scholar · View at Scopus
  51. J. Pumprla, K. Howorka, D. Groves, M. Chester, and J. Nolan, “Functional assessment of heart rate variability: physiological basis and practical applications,” International Journal of Cardiology, vol. 84, no. 1, pp. 1–14, 2002. View at Publisher · View at Google Scholar · View at Scopus
  52. D. Devos, M. Kroumova, R. Bordet et al., “Heart rate variability and Parkinson's disease severity,” Journal of Neural Transmission, vol. 110, no. 9, pp. 997–1011, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. R. E. Kleiger, P. K. Stein, M. S. Bosner, and J. N. Rottman, “Time domain measurements of heart rate variability,” Cardiology Clinics, vol. 10, no. 3, pp. 487–498, 1992. View at Google Scholar · View at Scopus
  54. P. K. Stein, M. S. Bosner, R. E. Kleiger, and B. M. Conger, “Heart rate variability: a measure of cardiac autonomic tone,” American Heart Journal, vol. 127, no. 5, pp. 1376–1381, 1994. View at Publisher · View at Google Scholar · View at Scopus
  55. M. F. Siddiqui, S. Rast, M. J. Lynn, A. P. Auchus, and R. F. Pfeiffer, “Autonomic dysfunction in Parkinson's disease: a comprehensive symptom survey,” Parkinsonism and Related Disorders, vol. 8, no. 4, pp. 277–284, 2002. View at Publisher · View at Google Scholar · View at Scopus